Avadel Pharma (AVDL) Misses Q3 EPS by 7c

Avadel Pharma (NASDAQ: AVDL) reported Q3 EPS of $0.00, $0.07 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $77.4 million versus the consensus estimate of $73.58 million.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Comcast may build data centers, NBCUniversal may enter video game business - Reuters
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'